Want to see INFU full AI Analyst Report?
Gross Margin by Segment
Shows gross profit as a percentage of revenue for each business line. For InfuSystem, it highlights whether higher‑margin services or equipment management are replacing lower‑margin product sales, signals pricing power or cost pressure, and reveals how shifts in mix affect overall profitability and sustainability.Device Solutions suffered a deep margin trough but has staged a sharp recovery driven by mix-shift away from the large GE contract toward higher‑margin field service work; that rebound is the chart’s headline and explains improved consolidated gross profit. Patient Services stays consistently high-margin, helped by wound‑care expansion, signaling the company is deliberately trading some top‑line scale for better profitability. ERP go‑live should cement efficiency gains, but near‑term project costs, lost GE revenue and wage/benefit pressures mean margin durability depends on execution and revenue replacement.
Date | Patient Services | Device Solutions |
|---|---|---|
Jun 30, 2026 | 61.80 | 43.70 |
Mar 31, 2026 | 64.80 | 46.30 |
Dec 31, 2025 | 63.55 | 40.96 |
Sep 30, 2025 | 64.76 | 39.44 |
Jun 30, 2025 | 64.15 | 37.35 |
Mar 31, 2025 | 63.47 | 37.80 |
Dec 31, 2024 | 64.61 | 32.24 |
Sep 30, 2024 | 65.98 | 32.27 |
Jun 30, 2024 | 66.40 | 21.22 |
Mar 31, 2024 | 66.02 | 27.78 |